Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.
- Daniel A. Salerno, MD, MS, Associate Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of Critical Care Services in the Respiratory Intensive Care Unit at Temple University Hospital, spoke with the Philadelphia Inquirer for an article about research into long COVID.
- Health.com interviewed Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, Clinical Professor and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy and Clinical Pharmacist Specialist in Infectious Diseases at Temple University Hospital, about the decision by the U.S. Food and Drug Administration (FDA) to revise the Emergency Use Authorization for Paxlovid to allow state-licensed pharmacists to prescribe the oral antiviral medication for COVID-19.
- Delana Wardlaw, MD, who practices at Temple Physicians, Inc. at Nicetown, offered insight to 6ABC for a segment about COVID-19. Dr. Wardlaw emphasized the importance of testing, vaccination and the increased accessibility of treatments that are available.